Browse studies
Find your next paid study
39 recruiting studies matching your filters
Phase 1
A Phase 1, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Cyclin A/B-RxL Inhibitor CID-078 in Patients With Advanced Solid Tumor Malignancies
This is a first-in-human, multicenter, open-label, phase 1 study to evaluate safety, tolerability, and efficacy of CID-078, a Cyclin A/B-RxL inhibitor, in pati…
Advanced Solid TumorMetastatic Solid TumorRefractory Solid Tumor+7 more
Estimated
~$10 – $8,750
Circle PharmaNCT06577987
Phase 1
Phase I Dose-Escalating Study of Combining Intravenous Tirapazamine and Transarterial Embolization (TAE) in Liver Cancer
This phase 1 study is to determine the optimal dose and tolerability of a hypoxia-activating agent, tirapazamine, when it is combined with embolization in live…
Hepatocellular CarcinomaGastrointestinal Cancer MetastaticNeuroendocrine Tumors
Estimated
~$10 – $8,750
Teclison Ltd.NCT02174549
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical tria…
Cancer, MetastaticCancerCancer of Pancreas+40 more
Estimated
~$10 – $1,050
Massive Bio, Inc.